Fundacio Sant Joan De Deu

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Polycystic ovary syndrome1 trial

Phase

• Phase 11 trial
• Phase 21 trial

Status

• Completed2 trials

Lead sponsor

• Fundacio Sant Joan De Deu1 trial
• Glaxosmithkline Research & Development Limited1 trial

Closed trials

• Completed

  A Phase II, randomised, multi-centric, multi-national clinical trial to evaluate the efficacy, tolerability, and safety of a fixed dose combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) for adolescent girls and young adult women (AYAs) with polycystic ovary syndrome (PCOS).

  NCT05394142· Phase 2· Fundacio Sant Joan De Deu· Source

• Completed

  Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumours

  2024-511071-16-00· Phase 1· Glaxosmithkline Research & Development Limited· Source